{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T17:47:44Z","timestamp":1782064064413,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,21]]},"DOI":"10.7759\/cureus.111245","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T17:02:03Z","timestamp":1782061323000},"source":"Crossref","is-referenced-by-count":0,"title":["Early Treatment-Related Mortality in Acute Leukemia: A Real-World, Single-Center Study From a Resource-Limited Setting"],"prefix":"10.7759","author":[{"given":"Noran","family":"AlJafar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamer","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talib","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaf","family":"Al-sulaitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2011.10.002","article-title":"Curing all patients with acute promyelocytic leukemia: are we there yet?","volume":"25","author":"Baljevic M","year":"2011","unstructured":"Baljevic M, Park JH, Stein E, Douer D, Altman JK, Tallman MS. Curing all patients with acute promyelocytic leukemia: are we there yet?. Hematol Oncol Clin North Am. 2011, 25:1215-33. 10.1016\/j.hoc.2011.10.002","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref2","article-title":"Incidence of thrombosis in adults with acute leukemia: a single center experience in Mexico","volume":"65","author":"Guzm\u00e1n-Uribe P","year":"2013","unstructured":"Guzm\u00e1n-Uribe P, Rosas-L\u00f3pez A, Zepeda-Le\u00f3n J, Crespo-Sol\u00eds E. Incidence of thrombosis in adults with acute leukemia: a single center experience in Mexico. Rev Invest Clin. 2013, 65:130-40.","journal-title":"Rev Invest Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-100669","article-title":"Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin","volume":"111","author":"de la Serna J","year":"2008","unstructured":"de la Serna J, Montesinos P, Vellenga E, et al.. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood. 2008, 111:3395-402. 10.1182\/blood-2007-07-100669","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01936.x","article-title":"Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia","volume":"108","author":"Di Bona E","year":"2000","unstructured":"Di Bona E, Avvisati G, Castaman G, Luce Vegna M, De Sanctis V, Rodeghiero F, Mandelli F. Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia. Br J Haematol. 2000, 108:689-95. 10.1046\/j.1365-2141.2000.01936.x","journal-title":"Br J Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401859","article-title":"Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group","volume":"14","author":"Fenaux P","year":"2000","unstructured":"Fenaux P, Chevret S, Guerci A, et al.. Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group. Leukemia. 2000, 14:1371-7. 10.1038\/sj.leu.2401859","journal-title":"Leukemia"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204763","article-title":"All trans retinoic acid in acute promyelocytic leukemia","volume":"20","author":"Degos L","year":"2001","unstructured":"Degos L, Wang ZY. All trans retinoic acid in acute promyelocytic leukemia. Oncogene. 2001, 20:7140-5. 10.1038\/sj.onc.1204763","journal-title":"Oncogene"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-276196","article-title":"Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group","volume":"116","author":"Lo-Coco F","year":"2010","unstructured":"Lo-Coco F, Avvisati G, Vignetti M, et al.. Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group. Blood. 2010, 116:3171-9. 10.1182\/blood-2010-03-276196","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-346437","article-title":"Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid","volume":"118","author":"Park JH","year":"2011","unstructured":"Park JH, Qiao B, Panageas KS, et al.. Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood. 2011, 118:1248-54. 10.1182\/blood-2011-04-346437","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2462","article-title":"Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group","volume":"103","author":"Sanz MA","year":"2004","unstructured":"Sanz MA, Mart\u00edn G, Gonz\u00e1lez M, et al.. Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group. Blood. 2004, 103:1237-43. 10.1182\/blood-2003-07-2462","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.78","article-title":"Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry","volume":"25","author":"Lehmann S","year":"2011","unstructured":"Lehmann S, Ravn A, Carlsson L, et al.. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia. 2011, 25:1128-34. 10.1038\/leu.2011.78","journal-title":"Leukemia"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V92.8.2712","article-title":"Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group","volume":"92","author":"De Botton S","year":"1998","unstructured":"De Botton S, Dombret H, Sanz M, et al.. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood. 1998, 92:2712-8.","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13189","article-title":"Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis","volume":"168","author":"Daver N","year":"2015","unstructured":"Daver N, Kantarjian H, Marcucci G, et al.. Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis. Br J Haematol. 2015, 168:646-53. 10.1111\/bjh.13189","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403665","article-title":"Causes of death--other than progressive leukemia--in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience","volume":"19","author":"Slats AM","year":"2005","unstructured":"Slats AM, Egeler RM, van der Does-van den Berg A, et al.. Causes of death--other than progressive leukemia--in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience. Leukemia. 2005, 19:537-44. 10.1038\/sj.leu.2403665","journal-title":"Leukemia"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600724","article-title":"Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy","volume":"88","author":"Ray-Coquard I","year":"2003","unstructured":"Ray-Coquard I, Borg C, Bachelot T, et al.. Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy. Br J Cancer. 2003, 88:181-6. 10.1038\/sj.bjc.6600724","journal-title":"Br J Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08389.x","article-title":"Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003","volume":"151","author":"Molgaard-Hansen L","year":"2010","unstructured":"Molgaard-Hansen L, M\u00f6tt\u00f6nen M, Glosli H, J\u00f3nmundsson GK, Abrahamsson J, Hasle H. Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003. Br J Haematol. 2010, 151:447-59. 10.1111\/j.1365-2141.2010.08389.x","journal-title":"Br J Haematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.01.191","article-title":"Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98","volume":"22","author":"Creutzig U","year":"2004","unstructured":"Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol. 2004, 22:4384-93. 10.1200\/JCO.2004.01.191","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.08.008","article-title":"Treatment-related mortality in children with cancer: prevalence and risk factors","volume":"121","author":"Loeffen EA","year":"2019","unstructured":"Loeffen EA, Knops RR, Boerhof J, et al.. Treatment-related mortality in children with cancer: prevalence and risk factors. Eur J Cancer. 2019, 121:113-22. 10.1016\/j.ejca.2019.08.008","journal-title":"Eur J Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10874","article-title":"Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines","volume":"92","author":"J\u00e1como RH","year":"2007","unstructured":"J\u00e1como RH, Melo RA, Souto FR, et al.. Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines. Haematologica. 2007, 92:1431-2. 10.3324\/haematol.10874","journal-title":"Haematologica"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.017962","article-title":"Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high WBC count, late diagnosis and delayed treatment initiation","volume":"95","author":"Breccia M","year":"2010","unstructured":"Breccia M, Latagliata R, Cannella L, Minotti C, Meloni G, Lo-Coco F. Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high WBC count, late diagnosis and delayed treatment initiation. Haematologica. 2010, 95:853-4. 10.3324\/haematol.2009.017962","journal-title":"Haematologica"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00115-5","article-title":"Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial","volume":"2","author":"Iland HJ","year":"2015","unstructured":"Iland HJ, Collins M, Bradstock K, et al.. Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial. Lancet Haematol. 2015, 2:e357-66. 10.1016\/S2352-3026(15)00115-5","journal-title":"Lancet Haematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00197-7","article-title":"Classification of treatment-related mortality in children with cancer: a systematic assessment","volume":"16","author":"Alexander S","year":"2015","unstructured":"Alexander S, Pole JD, Gibson P, et al.. Classification of treatment-related mortality in children with cancer: a systematic assessment. Lancet Oncol. 2015, 16:e604-10. 10.1016\/S1470-2045(15)00197-7","journal-title":"Lancet Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604895","article-title":"Incidence and predictors of treatment-related mortality in paediatric acute leukaemia in El Salvador","volume":"100","author":"Gupta S","year":"2009","unstructured":"Gupta S, Bonilla M, Fuentes SL, et al.. Incidence and predictors of treatment-related mortality in paediatric acute leukaemia in El Salvador. Br J Cancer. 2009, 100:1026-31. 10.1038\/sj.bjc.6604895","journal-title":"Br J Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1023\/a:1008366814109","article-title":"Acute lymphoblastic leukemia in India: an analysis of prognostic factors using a single treatment regimen","volume":"10","author":"Advani S","year":"1999","unstructured":"Advani S, Pai S, Venzon D, et al.. Acute lymphoblastic leukemia in India: an analysis of prognostic factors using a single treatment regimen. Ann Oncol. 1999, 10:167-76. 10.1023\/a:1008366814109","journal-title":"Ann Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-216457","article-title":"How I treat acute promyelocytic leukemia","volume":"114","author":"Tallman MS","year":"2009","unstructured":"Tallman MS, Altman JK. How I treat acute promyelocytic leukemia. Blood. 2009, 114:5126-35. 10.1182\/blood-2009-07-216457","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.7525","article-title":"Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment","volume":"29","author":"Walter RB","year":"2011","unstructured":"Walter RB, Othus M, Borthakur G, et al.. Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. J Clin Oncol. 2011, 29:4417-23. 10.1200\/JCO.2011.35.7525","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/499994-early-treatment-related-mortality-in-acute-leukemia-a-real-world-single-center-study-from-a-resource-limited-setting","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T17:02:04Z","timestamp":1782061324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/499994-early-treatment-related-mortality-in-acute-leukemia-a-real-world-single-center-study-from-a-resource-limited-setting"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.111245","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,21]]}}}